[Behavior of serum lactic dehydrogenase (LDH) in disseminated breast cancer treated with delta-1-testololactone].
作者信息
MARGOTTINI M, JACOBELLI G, CAU M
出版信息
Gazz Int Med Chir. 1962 Dec 31;66:2890-9.
PMID:13933033
Abstract
摘要
相似文献
1
[Behavior of serum lactic dehydrogenase (LDH) in disseminated breast cancer treated with delta-1-testololactone].
Gazz Int Med Chir. 1962 Dec 31;66:2890-9.
2
[THE HORMONAL TREATMENT OF ADVANCED BREAST CANCER. STUDY METHODS: COMPARISON OF DELTA-1-TESTOLOLACTONE WITH TESTOSTERONE PROPIONATE].
Acta Clin Belg. 1963;18:469-79. doi: 10.1080/17843286.1963.11717155.
3
[HORMONE TREATMENT OF BREAST CANCER IN THE ADVANCED PHASE. COMPARISON BETWEEN TESTOSTERONE PROPIONATE AND THE TESTOSTERONE-DELTA-1-TESTOLOLACTONE COMBINATION].
Rev Fr Etud Clin Biol. 1964 Jan;9:88-90.
4
[COMPARATIVE METHODICAL STUDY OF TESTOSTERONE PROPIONATE AND DELTA-1-TESTOLACTONE IN THE TREATMENT OF ADVANCED BREAST CANCER. PERSONAL EXPERIENCE WITHIN THE "EUROPEAN BREAST CANCER GROUP"].
Bull Mem Soc Med Hop Paris. 1963 Jun 28;114:957-65.
5
TREATMENT OF ADVANCED BREAST CARCINOMA WITH DELTA 1-TESTOLOLACTONE.
Acta Unio Int Contra Cancrum. 1964;20:429-31.
6
Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.
Cancer Chemother Rep. 1970 Aug;54(4):249-53.
7
High-dosage delta-1-testololactone therapy of disseminated carcinoma of the breast.
Cancer. 1967 Mar;20(3):458-61. doi: 10.1002/1097-0142(1967)20:3<458::aid-cncr2820200314>3.0.co;2-u.
8
MICROBIAL FORMATION AND HYDROLYSIS OF TESTOLOLACTONE.
Arch Biochem Biophys. 1963 Oct;103:105-10. doi: 10.1016/0003-9861(63)90015-8.
9
Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion.
Cancer. 1960 Sep-Oct;13:1017-20. doi: 10.1002/1097-0142(196009/10)13:5<1017::aid-cncr2820130523>3.0.co;2-1.
10
Metabolism in vivo of delta 1-testololactone.
J Biol Chem. 1961 Oct;236:2624.
Zotero 插件